1. Angst J. (1987). Verlauf der affectiven Psychosen (S. verlag, Ed.

) Psychiatrie der Gegenwart,

115-136

2. Michael Gelder (1994) Tratat de psihiatrie (Denis Gath, Richard Mayou) 213-240; 399-430

3. Beck A. T. (1973). The diagnosis and management of Depression. Philadelphia : Univ

Pennsylvania Press.

4. A. E. Jorm. The epidemiology of depressive states in the elderly: Implications for a

recognition, intervention and prevention. Soc Psychiatry Psychiatr Epidemiol (1995) 30:53-59

5.American Psychiatric Association (2013) : Diagnostic and Statistical Manual of Mental

Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association

6. Lamosin F, Manetti A, Rene M, Schuster JP.(2015): Depression du sujet age : donnees

epidemiologiques, espects cliniques et approaches therapeutiques specifiques. Elsevier Masson;
15,256-261

7. Boișteanu P, Naum E. (2012) Cercetări Clinico-Experimentale în Alcoologie. Tipo Moldova.

8. Ingram R. Depression. Encyclopedia of Mental Health Elsevier 2016.

9. Del Boca FK & Hesselbrock MN (1995): Types of alcoholics: A reanalysis of risk, severity,
and gender, paper presented at the Research Society on Alcoholism, Steamboat Spring,
Colorado, USA

10. Berrs Mark H., Porter Robert S. (2014) ; The Merck Manual of Diagnosis and Therapy. 18th
Edition; 1722-1731

11. Smart RG, Mann RE: Alcohol and epidemiology of liver cirrhosis, Alcohol Health &
Research World, 1992, 12: 217-222;

12. Prelipceanu D, Mihăilescu R, Teodorescu R.(2000) Tratat de Sănătate Mintală.

București:Ed. Enciclopedică.

13. Spitzer, R. L., & Endicott, J. (1978). Schedule of Affective Disorders and Schizophrenia. 3rd
ed. New York: Biomentrics Research

14.Răducanu I., Fulga I. Ionescu C., Implicațiile clinice ale utilizării scalei de depresie
geriatrică (GDS) ca instrument de screening pentru depresie la pacienții vârstnici. Institul
Național de Gerontologie și Geriatrie „Ana Aslan”, București, Universitatea de Medicină și
Farmacie „Carol Davila” , București.

15. Del Boca F & Hesselbrock MN (1996): Gender and alcoholic subtypes, Alcohol Health &
Research World, Vol 20, 56-62
16. American Psychiatric Association DSM-5, Task Force (2013). Diagnostic and Statistical
Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association;

17. Jablensky A. (2010). The diagnostic concept of schizophrenia: its history, evolution, and
fututre prospects. Dialogues Clin Neurosci.2010; 12:271-287

18. Stanciu C, Trifan A, (2012) Gastroenterologie. Iași, Ed “Gr. T. Popa”

19. Payneau C, Koskas P, Drunat O. Depression du sujet age: l’affaire du psychiatre. Elsevier
Masson 2014: 14, 259-264

20. World Health Organization accesat la data de 09.03.2018

http://www.who.int/mental_health/management/depression/en .

21. Hellemans Mariette (1997). The concept of Quality of Life, in Quality of Life, Fracaritatis,
Gent., 47-56.

22. Predescu V. (1998) Psihiatrie. București: Editura Medicală. 1:238-296, 2: 553-558

23. Levitt MD. (1998) Use of a two-compartment model to assess the pharmacokinetics of
human ethanol metabolism. Minnesota, Minneapolis Veterans Affairs Medical Center.

24. Rigaud AS, Bayle C, Latour F, Lenoir H et col. (2005) Troubles psychiques des personnes
agees. Elsevier .

25. Kumar M, Chandu GN, Shafiulla Md. Oral health status and treatment needs in
institutionalized psychiatric patients: one year descriptive cross sectional study. Indian J Dent
Res. 2006;17(4):171–77.

26. Kebede B, Kemal T, Abera S. Oral health status of patients with mental disorders in
Southwest Ethiopia. PLoS One. 2012;7(6):e39142.

27. World Health Organisation. (1998) The ICD X- Classification of Mental and Behavioural
Disorders. Clinical Description and Diagnostic Guidelines. Geneva: WHO .

28. Wallace C.J., Lieberman R.P. (1995). Psychiatric rheabilitation, in Treatment of Psychiatric
Disorders, 2nd ed. Edit. Gabbard GO, Washington D.C., 1019-1038.

29.Chirița R. Calitatea vieții și managementul psihiatric în schizofrenie, Revista Română de

Psihiatrie

30.Thurman RG et al. Swift Increase in Alcohol Metabolism in Humans. Alcohol Clin Exp
Res.1989 Aug; 13(4):572-6.
31. Bertaud-Gounot V, Kovess-Masfety V, Perrus C, Trohel G, Richard F. Oral health status
and treatment needs among psychiatric inpatients in Rennes, France: a cross-sectional study.
BMC Psychiatry. 2013;13:227.

32. Jovanovic S, Milovanovic SD, Gajic I, Mandic J, Latas M, Jankovic L. Oral health status of
psychiatric in-patients in Serbia and implications for their dental care. Croat Med J.
2010;51(5):443–50.

33. Boris Luban-Plozza, Diamandescu IB - Dimensiunea psihosocialã a Practicii Medicale , Ed.

InfoMedica, Bucureoti,2002, 67-126


34. Usineviciu A, Molnar B, Szabo S, Crãciun C, Hristea M, Þerban M - Cercetãri privind starea
morfofuncþionalã a sistemului hipofizo-suprarenal la iepuri cu parodontozã
experimentalã,Stomatologia Bucureoti, vol.XXVII, nr.2, 1980, 81-96.

35. Shah VR, Jain P, Patel N. Oral health of psychiatric patients: A cross-sectional comparision
study. Dent Res J. 2012;9:209–14.

36. Diamandescu IB - Stresul psihic oi bolile interne-Ed.ALL, Bucureoti 1993, 1-44, 142-157


37.Hor K, Taylor M. (2010) Suicide and schizophrenia: a systematic review of rates and risk
factors. J Psychopharmacol; 24:81

38. Little WJ, Falace DA, Miller CS, Rhodus LN - Dental Management of the Medically
Compromised Patient, Chapter 28 Behavioral and Psychiatric Disorders (Anxiety, Delirum, and
Eating Disorders), Chapter 29- Psyhiatric Disorders, Seventh ed., Ed. Mosby Elsevier 2008,
488-506, 507-532

39. Gozdzik-Zelazny A, Borecki L, Pokorski M. (2011) Depressive symptoms in schizophrenic

patients. Eur J Med Res 16:549-5210

40. Pedersen MG, Stevens H, Pedersen CB, et al. (2011) Toxoplasma infection and later
development of schizophrenia in mothers. Am J Psychiatry; 168:814

41. Pratt J, Winchester C, Dawson N, Morris B. (2012) Advancing schizophrenia drug discovery:
optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov. 11(7):560-79

42. Stahl SM. (2013) Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical
Application, Fourth Edition. New York: Cambridge University Press.

43. McGrath JJ, Eyles DW, Pedersen CB, et al. (2010) Neonatal vitamin D status and risk of
chizophrenia: a population-based case-control study. Arch Gen Psychiatry 67:889
44.Azrin N. H. et al. Alcoholism Treatment by Disulfiram and Community Reinforcement
Therapy. Journal Of Behavior Therapy and Ecperimental Psychiatry. Vol 13, Issue 2, June 1982,
p.105-112

45. Salzman C (1999) Practical consideration for the treatment of depression in elderly and very
elderly long term care patients. J Clin Psychiatr, 20, 30-33

46. Negri, E.; La Vecchia, C.; Franceschi, S.; Tavani, A. Attributable risk for oral cancer in
Northern Italy. Cancer Epidemiol. Biomark. Prev. 1993, 2, 189–193. 


47. RobM. Kok, MD, PhD; Charles F. Reynolds III, MD (2017) Management of Depression in
Older Adults. A Review. JAMA; 317(20):2114-2122

48. Yokoyama, A.; Tsutsumi, E.; Imazeki, H.; Suwa, Y.; Nakamura, C.; Mizukami, T.;
Yokoyama, T. Salivary acetaldehyde concentration according to alcoholic beverage consumed
and aldehyde dehydrogenase-2 genotype. Alcohol. Clin. Exp. Res. 2008, 32, 1607–1614. 


49. Lachenmeier, D.W.; Monakhova, Y.B. Short-term salivary acetaldehyde increase due to
direct exposure to 
 alcoholic beverages as an additional cancer risk factor beyond ethanol
metabolism. J. Exp. Clin. Cancer Res. 
 2011, 30, 3.

50. Moos, Rudolf H. (1990) Alcoholism Treatment: Context, Proces and Outcome. New York,
U.S. Oxdort University Press

51. Yokoyama, A.; Tsutsumi, E.; Imazeki, H.; Suwa, Y.; Nakamura, C.; Yokoyama, T.
Polymorphisms of alcohol 
 dehydrogenase-1b and aldehyde dehydrogenase-2 and the blood
and salivary ethanol and acetaldehyde concentrations of Japanese alcoholic men. Alcohol. Clin.
Exp. Res. 2010, 34, 1246–1256. 


52. Cederbaum, A.I. Alcohol metabolism. Clin. Liver Dis. 2012, 16, 667–685. 


53. Sarkola, T.; Iles, M.R.; Kohlenberg-Mueller, K.; Eriksson, C.J. Ethanol, acetaldehyde,
acetate, and lactate levels after alcohol intake in white men and women: Effect of 4-
methylpyrazole. Alcohol. Clin. Exp. Res. 2002, 26, 239–245. 


54.Desvarieux M, Demmer R, Rundek Y, Boden-Albala B, Jacobs D, Papapanou P: Relationship

between periodontal disease, tooth loss, and carotid artery plaque : the Oral Infections and
Vascular Disease Epidemiology Study (INVEST) Stroke 2003 , 34:2120-2125

55. Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M: Modifiable risk factors for
nursing home acquired pneumonia. Clin Infect Dis 2005, 40(1):1-6

56. Kumar M, Chandu G, Shafiulla M. Oral health status and treatment needs in
institutionalized psychiatric patients: one year descriptive cross sectional study. Indian J Dent
Res. 2006;17(4):171–177.

57. Dumitriu H. T, Dumitriu S, Dumitriu A S (2009) Parodontologie; 153.

58. Homann, N.; Jousimies-Somer, H.; Jokelainen, K.; Heine, R.; Salaspuro, M. High
acetaldehyde levels in saliva after ethanol consumption: Methodological aspects and
pathogenetic implications. Carcinogenesis 1997, 18, 1739–1743. 


59.Popescu E, Popa C, Gogălniceanu D (2008) Medicină orală; 187

60. Lasmter I, Lalla E, Borgnakke W, Taylor G: The relationship between oral health and
diabetes mellitus. L Am Dent Assoc 2008, 139:19S-24S

61. Ramon T, Grinshpoon A, Zusman S, Weizman A. Oral health and treatment needs of
institutionalized chronic psychiatric patients in Israel. Eur Psychiatry. 2003;18(3):101–105.

62. Tang W, Sun F, Ungvari G, O’Donnell D. Oral health of psychiatric in-patients in

HongKong. Int J Soc Psychiatry. 2004;50(2):186–191

63. Mirza I, Day R, Wulff-Cochrane V, Phelan M. Oral health of psychiatric in-patients. A point
prevalence survey of an inner-city hospital. Psychiatr Bull. 2001;25:143–145.

64. Zusman S, Ponizovsky A, Dekel D, Masarwa A, Ramon T, Natapov L. An assessment of the

dental health of chronic institutionalized patients with psychiatric disease in Israel. Spec Care
Dentist. 2010;30(1):18–22.

65. Jovanovic S, Milovanovic S, Gajic I, Mandic J, Latas M, Jankovic L. Oral health status of
psychiatric in-patients in Serbia and implications for their dental care. Public Health.
2010;51:443–450.

66. Chu K, Yang N, Chou P, Chiu H, Chi L. Factors associated with dental caries among
institutionalized residents with schizophrenia in Taiwan: a cross-sectional study. BMC Publ
Health. 2010;10:482.

67. Farrahi-Avval N. Oral health status and treatment needs of the Institutionalized chronic
psychiatric patients in two Ontario Psychiatric Care Centres. Toronto: Oral Health Status and
Treatment Needs of the Institutionalized; 2008. (PhD thesis).

68. Hede B. Oral health in Danish hospitalized psychiatric patients. Community Dent Oral
Epidemiol. 1995;23:44–48.
69. Kisely S, Quek LH, Pais J, et al. Advanced dental disease in people with severe mental
illness: Systematic review and meta-analysis. Br J Psychiatry 2011;199:187-193.

70. Chu K, Yang N, Chou P, Chi L, Chiu H. The relationship between body mass index, the use
of second generation antipsychotics, and dental caries among hospitalized patients with
schizophrenia. Int J Psychiatr Med. 2011;41(4):343–353.

71. Sjögren R, Nordström G. Oral health status of psychiatric patients. J Clin Nurs 2000 9:632-
638

72. Tani H, Uchida H, Suzuki T, et al. Dental conditions in inpatients with schizophrenia: A
large-scale multi-site survey. BMC Oral Health 2012; 12:32.

73. Culpepper L. A roadmap to key pharmacologic principles in using antipsychotics. Prim Care
Comp J Ass Med Psychiatry 2007;9:444–454.

74. Bassett A, Remick RA, Blasberg B. Tardive dyskinesia: An unrecognised cause of orofacial
pain. Oral Surg Oral Med Oral Pathol 1986;61:570–572.

75. Pajukoski H, Meurman JH, Halonen P, et al. Prevalence of subjective dry mouth and burning
mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and
systemic diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:641-649.

76. Nielsen J, Munk-Jørgensen P, Skadhede S, Correll CU. Determinants of poor dental care in
patients with schizophrenia: A historical, prospective database study. J Clin Psychiatry
2011;72:140-143.

77. Dorsey ER, Rabbani A, Gallagher SA, et al. Impact of FDA black box advisory on
antipsychotic medication use. Arch Intern Med 2011;170: 96–103.

78. Ozbilen M, Adams CE, Marley J. Anticholinergic effects of oral antipsychotic drugs of
typicals versus atypicals over medium- and long-term: Systematic review and meta-analysis.
Curr Med Chem 2012;19:5214-5218.

79. Lewis S, Jagger R, Treasure E. The oral health of psychiatric in-patients in South Wales.
Spec Care Dentist. 2001;21:182–186.